Exploring metabolomics biomarkers for evaluating the effectiveness of concurrent radiochemotherapy for cervical cancers

BACKGROUND: Cervical cancer is the second most common female malignancy worldwide. The main method to evaluate the effect of concurrent chemoradiotherapy (CCRT) in the locally advanced stage is imaging which cannot meet the clinical needs. This study aimed to explore potential cervical cancer biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Huihui, Li, Qi, Wang, Tong, Liang, Hong, Wang, Yanan, Duan, Yani, Song, Min, Wang, Yaoxian, Jin, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797309/
https://www.ncbi.nlm.nih.gov/pubmed/35117632
http://dx.doi.org/10.21037/tcr.2020.02.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797309/
https://www.ncbi.nlm.nih.gov/pubmed/35117632
http://dx.doi.org/10.21037/tcr.2020.02.49

Ejemplares similares